You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al

Article metrics

Article menu

Download PDFPDF

Letter
Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al

 

Online download statistics by month:

Online download statistics by month: March 2023 to August 2025

AbstractFullPdf
Mar 2023020436
Apr 2023012630
May 202308415
Jun 202307116
Jul 202306216
Aug 20230837
Sep 202306410
Oct 202304214
Nov 202305811
Dec 202303210
Jan 202402813
Feb 202402110
Mar 202402710
Apr 20240114
May 202402910
Jun 202403518
Jul 20240349
Aug 202403112
Sep 202402416
Oct 202402917
Nov 202402312
Dec 20240305
Jan 202502017
Feb 20250513
Mar 202503111
Apr 202505221
May 202502325
Jun 20250167
Jul 2025010
Aug 2025010
Total01343385